Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 7, 2014; 20(17): 5119-5123
Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.5119
Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.5119
Efficacy of ilaprazole in the treatment of duodenal ulcers: A meta-analysis
Xi-Qing Ji, Jun-Feng Du, Gang Chen, Guang Chen, Bo Yu, Department of General Surgery, General Hospital of Beijing Military Command of People’s Liberation Army, Beijing 100700, China
Author contributions: Ji XQ and Yu B designed research; Ji XQ, Du JF and Chen G performed research; Ji XQ, Chen G and Yu B wrote the paper.
Supported by The National Natural Science Foundation of China, No. 81000189
Correspondence to: Bo Yu, MD, Department of General Surgery, General Hospital of Beijing Military Command of People’s Liberation Army, No. 5, Nanmencang, Dongsi, Beijing 100700, China. yubobeizong@126.com
Telephone: +86-10-84008099 Fax: +86-10-66721188
Received: October 21, 2013
Revised: January 22, 2014
Accepted: March 8, 2014
Published online: May 7, 2014
Processing time: 197 Days and 12.1 Hours
Revised: January 22, 2014
Accepted: March 8, 2014
Published online: May 7, 2014
Processing time: 197 Days and 12.1 Hours
Core Tip
Core tip: Ilaprazole, a proton pump inhibitor (PPI), is a newly developed medicine in the management of acid-related disorders. This meta-analysis showed that ilaprazole was a highly effective and safe PPI compared with other PPIs in the treatment of duodenal ulcer. Ilaprazole can be recommended as a therapy for acid-related disorders, especially in Asian populations.